arrow
L

Loay Kassem

Fayoum University
H指数:18
被引数:1,191

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumab

埃及高风险、早期三阴性乳腺癌治疗的成本效益分析:新辅助培美曲塞联合化疗,随后辅助单药培美曲塞的分析

2025-01-030
OA
Tailoring neo/adjuvant systemic therapy in breast cancer: The advent of a personalized approach-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations

定制乳腺癌的新/辅助系统治疗: 个性化方法的出现-乳腺妇科和免疫肿瘤学国际癌症会议 (BGICC) 共识和建议

CANCER
IF5.1
2024-07-100
PRE
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
2023-03-0613
OAAI
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant

用PI3K抑制剂alpelisib (BYL719) 和氟维司群联合治疗的乳腺癌PDX模型中雌激素受体的基因组和非基因组信号传导分析

2021-05-2112
OAAI